WallStSmart

Bioceres Crop Solutions Corp (BIOX)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 8477% more annual revenue ($27.29B vs $318.16M). NTR leads profitability with a 8.7% profit margin vs -17.7%. NTR appears more attractively valued with a PEG of 1.35. NTR earns a higher WallStSmart Score of 59/100 (C).

BIOX

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 2.0Value: 4.7Quality: 2.5
Piotroski: 3/9Altman Z: 0.51

NTR

Buy

59

out of 100

Grade: C

Growth: 3.3Profit: 6.5Value: 5.3Quality: 6.5
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BIOX.

NTRSignificantly Overvalued (-29.7%)

Margin of Safety

-29.7%

Fair Value

$56.35

Current Price

$78.45

$22.10 premium

UndervaluedFair: $56.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BIOX2 strengths · Avg: 9.0/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

NTR3 strengths · Avg: 8.7/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.99B8/10

Generating 2.0B in free cash flow

Areas to Watch

BIOX4 concerns · Avg: 3.0/10
PEG RatioValuation
1.954/10

Expensive relative to growth rate

Market CapQuality
$26.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-359.8%2/10

ROE of -359.8% — below average capital efficiency

NTR3 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

EPS GrowthGrowth
1.2%4/10

1.2% earnings growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BIOX

The strongest argument for BIOX centers on Price/Book, EPS Growth.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, P/E Ratio, Free Cash Flow. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : BIOX

The primary concerns for BIOX are PEG Ratio, Market Cap, Piotroski F-Score. Debt-to-equity of 3.76 is elevated, increasing financial risk.

Bear Case : NTR

The primary concerns for NTR are Revenue Growth, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

BIOX profiles as a turnaround stock while NTR is a value play — different risk/reward profiles.

NTR carries more volatility with a beta of 1.08 — expect wider price swings.

NTR is growing revenue faster at 4.0% — sustainability is the question.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NTR scores higher overall (59/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bioceres Crop Solutions Corp

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Bioceres Crop Solutions Corp.

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?